The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trialBehrouz Kassaï, Tiphanie Ginhoux, Emeline Peyric et al.|Orphanet Journal of Rare Diseases|2014Cited by 57
Assessment of mineral and bone biomarkers highlights a high frequency of hypercalciuria in asymptomatic healthy teenagersJustine Bacchetta, Christelle Roger, Tiphanie Ginhoux et al.|Acta Paediatrica|2019Cited by 19
Skin microvascular dysfunction as an early cardiovascular marker in primary hyperoxaluria type IAlexandra Bruel, Laurence Dubourg, Justine Bacchetta et al.|Pediatric Nephrology|2018Cited by 5
Évaluation comportementale et neuropsychologique d’une population d’enfants atteints de neurofibromatose de type 1 traites par méthylphenidate : une étude en plan croisé, randomisée en double insu du méthylphenidate versus placeboLaurence Lion‐François, Behrouz Kassaï, François Gueyffier et al.|Archives de Pédiatrie|2013Cited by 0